Institutional Ownership Sage Therapeutics, Inc. (SAGE)
This table provides information about the institutional ownership of Sage Therapeutics, Inc. (SAGE). We have compiled data on the 194 institutions that hold shares in the stock, with a total of 45 Million shares, which have been reported (via 13F filing form) to have a value of $389 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
South State Corp
|
Feb 10, 2025 Q4 2024 |
9
shares
|
$74
0.0% of portfolio
|
Q3 2021
New holding
|
|
|
Covestor LTD
Boston, MA |
Feb 13, 2025 Q4 2024 |
7
shares
|
$57
0.0% of portfolio
|
Q4 2024
Added 16.67%
|
|
|
Wolff Wiese Magana LLC
|
Jan 14, 2025 Q4 2024 |
7
shares
|
$57
0.0% of portfolio
|
Q3 2023
Reduced 99.6%
|
|
|
Org Partners LLC
Roanoke, IN |
Jan 10, 2025 Q4 2024 |
5
shares
|
$41
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Ronald Blue Trust, Inc.
Brentwood, TN |
Jan 30, 2025 Q4 2024 |
2
shares
|
$16
0.0% of portfolio
|
Q4 2024
Reduced 99.63%
|
|
|
Activest Wealth Management
|
Jan 28, 2025 Q4 2024 |
1
shares
|
$8
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Ever Source Wealth Advisors, LLC
|
Feb 07, 2025 Q4 2024 |
1
shares
|
$8
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Huntington National Bank
Columbus, OH |
Feb 12, 2025 Q4 2024 |
1
shares
|
$8
0.0% of portfolio
|
Q2 2024
Reduced 98.97%
|
|
|
First Horizon Advisors, Inc.
|
Feb 03, 2025 Q4 2024 |
1
shares
|
$8
0.0% of portfolio
|
Q2 2022
Reduced 93.33%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
Closed
|